Regulations.gov document
Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological…
Notice · FDA-2019-D-4964 · posted Dec 20, 2019
Key facts
| Document ID | FDA-2019-D-4964-0001 |
|---|---|
| Title | Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products; Draft Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2019-D-4964 |
| Posted | Dec 20, 2019 |
| Federal Register citation | 84 FR 70196 |
| FR document number | 2019-27524 |
| Comment period opens | Dec 20, 2019 |
| Comments due | Feb 19, 2020 |
| Effective date | Dec 20, 2019 |
At a glance
- 1–9 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: